Related Experiment Video
Updated: Jun 23, 2025
04:48
Author Spotlight: Advancements in Cell and Tissue Engineering for Tendon Repair
Published on: March 1, 2024
1.6K
iPS cell therapy 2.0: Preparing for next-generation regenerative medicine
Kelvin K Hui1, Shinya Yamanaka1,2,3
1Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.
Summary
Induced pluripotent stem cells (iPSCs) show promise in regenerative medicine, with ongoing clinical trials. Future strategies can enhance iPSC therapies by incorporating bioengineering for personalized and designer medical applications.
Area of Science:
- Regenerative Medicine
- Biotechnology
- Cell Therapy
Background:
- The tenth anniversary of the first transplantation of induced pluripotent stem cell (iPSC)-derived tissue highlights advancements in regenerative medicine.
- Numerous global clinical trials are evaluating the safety and efficacy of iPSC-derived products for various diseases.
Purpose of the Study:
- To strategize for next-generation iPSC-based therapies.
- To explore lessons learned from chimeric antigen receptor (CAR) T-cell therapy development.
- To identify opportunities for integrating bioengineering technologies into iPSC applications.
Main Methods:
- Review of clinical trial data for iPSC-derived products.
- Analysis of developmental strategies for CAR T-cell therapy.
- Exploration of emerging bioengineering technologies, including RNA engineering and tissue fabrication.
Main Results:
- iPSC technology has progressed significantly over the past decade.
- Clinical trials are actively investigating iPSC therapies for diverse pathologies.
- Bioengineering offers potential to advance iPSC applications beyond personalized medicine.
Conclusions:
- Strategic planning is crucial for the future of iPSC-based therapies.
- Lessons from CAR T-cell therapy can inform iPSC therapeutic development.
- Integration of advanced bioengineering can create novel "designer" medical applications using iPSCs.
Related Concept Videos
01:22iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
01:21Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
01:17Stem Cell Culture
5.1K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.1K
01:13Induced Pluripotent Stem Cells
22.4K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
22.4K
01:21EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
01:24Methods of Nuclear Reprogramming
1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K